[1] RAHMANI A, SALEKI K, JAVANMEHR N, et al. Mesenchymal stem cell-derived extracellular vesicle-based therapies protect against coupled degeneration of the central nervous and vascular systems in stroke. Ageing Res Rev. 2020;62:101106.
[2] HOCUM STONE LL, XIAO F, ROTSCHAFER J, et al. Amelioration of Ischemic Brain Injury in Rats With Human Umbilical Cord Blood Stem Cells: Mechanisms of Action. Cell Transplant. 2016;25(8):1473-1488.
[3] CHEN X, ARUMUGAM TV, CHENG YL, et al. Combination Therapy with Low-Dose IVIG and a C1-esterase Inhibitor Ameliorates Brain Damage and Functional Deficits in Experimental Ischemic Stroke. Neuromolecular Med. 2018;20(1):63-72.
[4] BARTHELS D, DAS H. Current advances in ischemic stroke research and therapies. Biochim Biophys Acta Mol Basis Dis. 2020;1866(4):165260.
[5] ZIVIN JA. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Ann Neurol. 2009;66(1):6-10.
[6] THÉRY C, WITWER KW, AIKAWA E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.
[7] LI Y, CHENG Q, HU G, et al. Extracellular vesicles in mesenchymal stromal cells: A novel therapeutic strategy for stroke. Exp Ther Med. 2018;15(5):4067-4079.
[8] DOEPPNER TR, HERMANN DM. Editorial: Stem cells and progenitor cells in ischemic stroke-fashion or future? Front Cell Neurosci. 2015;9:334.
[9] XIONG Y, MAHMOOD A, CHOPP M. Emerging potential of exosomes for treatment of traumatic brain injury. Neural Regen Res. 2017;12(1):19-22.
[10] LIU W, BAI X, ZHANG A, et al. Role of Exosomes in Central Nervous System Diseases. Front Mol Neurosci. 2019;12:240.
[11] XIN H, LI Y, CUI Y, et al. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 2013;33(11):1711-1715.
[12] WEI M, WANG D, KANG D, et al. Overview of Cochrane reviews on Chinese herbal medicine for stroke. Integr Med Res. 2020;9(1):5-9.
[13] LIU R, YU X, ZHANG L, et al. Computed tomography (CT) imaging evaluation of integrated traditional Chinese medicine cooperative therapy in treating acute cerebral infarction: A randomized controlled trial. Medicine (Baltimore). 2020;99(18):e19998.
[14] KALANI A, CHATURVEDI P. Curcumin-primed and curcumin-loaded exosomes: potential neural therapy. Neural Regen Res. 2017;12(2): 205-206.
[15] OTERO-ORTEGA L, GUTIÉRREZ-FERNÁNDEZ M, RAMOS-CEJUDO J, et al. White matter injury restoration after stem cell administration in subcortical ischemic stroke. Stem Cell Res Ther. 2015;6(1):121.
[16] ZHANG HT, LIU ZL, YAO XQ, et al. Neural differentiation ability of mesenchymal stromal cells from bone marrow and adipose tissue: a comparative study. Cytotherapy. 2012;14(10):1203-1214.
[17] LALU MM, MONTROY J, DOWLATSHAHI D, et al. From the Lab to Patients: a Systematic Review and Meta-Analysis of Mesenchymal Stem Cell Therapy for Stroke. Transl Stroke Res. 2020;11(3):345-364.
[18] 钱楠楠,张潜,杨睿,等.间充质干细胞治疗脊髓损伤:细胞治疗及联合新药和生物材料[J].中国组织工程研究,2021,25(13):2114-2120.
[19] KAWABORI M, SHICHINOHE H, KURODA S, et al. Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke. Int J Mol Sci. 2020;21(19): 7380.
[20] BIANCONE L, BRUNO S, DEREGIBUS MC, et al. Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant. 2012;27(8):3037-3042.
[21] DENG Y, CHEN D, GAO F, et al. Exosomes derived from microRNA-138-5p-overexpressing bone marrow-derived mesenchymal stem cells confer neuroprotection to astrocytes following ischemic stroke via inhibition of LCN2. J Biol Eng. 2019;13:71.
[22] PASHOUTAN SARVAR D, SHAMSASENJAN K, AKBARZADEHLALEH P. Mesenchymal Stem Cell-Derived Exosomes: New Opportunity in Cell-Free Therapy. Adv Pharm Bull. 2016;6(3):293-299.
[23] GUDURIC-FUCHS J, O’CONNOR A, CAMP B, et al. Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genomics. 2012;13:357.
[24] RAPOSO G, STOORVOGEL W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373-383.
[25] DEHGHANI L, HASHEMI SM, SAADATNIA M, et al. Stem Cell-Derived Exosomes as Treatment for Stroke: a Systematic Review. Stem Cell Rev Rep. 2021;17(2):428-438.
[26] XING H, LIANG C, XU X, et al. Mesenchymal stroma/stem-like cells of GARP knockdown inhibits cell proliferation and invasion of mouse colon cancer cells (MC38) through exosomes. J Cell Mol Med. 2020; 24(23):13984-13990.
[27] TAN Q, XIA D, YING X. miR-29a in Exosomes from Bone Marrow Mesenchymal Stem Cells Inhibit Fibrosis during Endometrial Repair of Intrauterine Adhesion. Int J Stem Cells. 2020;13(3):414-423.
[28] MIZUTA Y, AKAHOSHI T, GUO J, et al. Exosomes from adipose tissue-derived mesenchymal stem cells ameliorate histone-induced acute lung injury by activating the PI3K/Akt pathway in endothelial cells. Stem Cell Res Ther. 2020;11(1):508.
[29] NETTO JP, ILIFF J, STANIMIROVIC D, et al. Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol. Neurosurgery. 2018;82(6):770-780.
[30] GE X, LI W, HUANG S, et al. Increased miR-21-3p in Injured Brain Microvascular Endothelial Cells after Traumatic Brain Injury Aggravates Blood-Brain Barrier Damage by Promoting Cellular Apoptosis and Inflammation through Targeting MAT2B. J Neurotrauma. 2019;36(8): 1291-1305.
[31] LI C, FEI K, TIAN F, et al. Adipose-derived mesenchymal stem cells attenuate ischemic brain injuries in rats by modulating miR-21-3p/MAT2B signaling transduction. Croat Med J. 2019;60(5):439-448.
[32] ZUO X, LU J, MANAENKO A, et al. MicroRNA-132 attenuates cerebral injury by protecting blood-brain-barrier in MCAO mice. Exp Neurol. 2019;316:12-19.
[33] BIAN X, MA K, ZHANG C, et al. Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases. Stem Cell Res Ther. 2019;10(1):158.
[34] ZAGREAN AM, HERMANN DM, OPRIS I, et al. Multicellular Crosstalk Between Exosomes and the Neurovascular Unit After Cerebral Ischemia. Therapeutic Implications. Front Neurosci. 2018;12:811.
[35] MOON GJ, SUNG JH, KIM DH, et al. Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA Study. Transl Stroke Res. 2019;10(5):509-521.
[36] 胡琳,何圣佳,陈翠花,等.外泌体及其microRNA与缺血性脑卒中关系的研究进展[J].山东医药,2019,59(13):83-86.
[37] XIN H, LI Y, LIU Z, et al. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. 2013;31(12):2737-2746.
[38] XIN H, KATAKOWSKI M, WANG F, et al. MicroRNA cluster miR-17-92 Cluster in Exosomes Enhance Neuroplasticity and Functional Recovery After Stroke in Rats. Stroke. 2017;48(3):747-753.
[39] CHOPP M, ZHANG ZG. Emerging potential of exosomes and noncoding microRNAs for the treatment of neurological injury/diseases. Expert Opin Emerg Drugs. 2015;20(4):523-526.
[40] ZHANG Y, UENO Y, LIU XS, et al. The MicroRNA-17-92 cluster enhances axonal outgrowth in embryonic cortical neurons. J Neurosci. 2013; 33(16):6885-6894.
[41] CHEN KH, CHEN CH, WALLACE CG, et al. Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke. Oncotarget. 2016;7(46):74537-74556.
[42] WANG Z, YUAN Y, ZHANG Z, et al. Inhibition of miRNA-27b enhances neurogenesis via AMPK activation in a mouse ischemic stroke model. FEBS Open Bio. 2019;9(5):859-869.
[43] 安阳方,曹建华,汤永红.间充质干细胞来源外泌体在缺血性脑卒中的研究进展[J].中南医学科学杂志,2019,47(4):442-445.
[44] KRISHNAN S, LAWRENCE CB. Old Dog New Tricks; Revisiting How Stroke Modulates the Systemic Immune Landscape. Front Neurol. 2019;10: 718.
[45] CECI M, MARIANO V, ROMANO N. Zebrafish as a translational regeneration model to study the activation of neural stem cells and role of their environment. Rev Neurosci. 2018;30(1):45-66.
[46] JIANG M, WANG H, JIN M, et al. Exosomes from MiR-30d-5p-ADSCs Reverse Acute Ischemic Stroke-Induced, Autophagy-Mediated Brain Injury by Promoting M2 Microglial/Macrophage Polarization. Cell Physiol Biochem. 2018;47(2):864-878.
[47] DOEPPNER TR, HERZ J, GÖRGENS A, et al. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression. Stem Cells Transl Med. 2015;4(10):1131-1143.
[48] ZHANG L, YU D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019;1871(2):455-468.
[49] 袁鹏,郭晓辰,张军平,等.外泌体对动脉粥样硬化的调控机制及中药干预作用[J].中国中西医结合杂志,2019,39(2):251-255.
[50] 李思迪,侯信,亓洪昭,等.外泌体:为高效药物投递策略提供天然的内源性纳米载体[J].化学进展,2016,28(Z2):353-362.
[51] 刘儒涛,王世伟,刘晶.细胞间信息交流的新载体——外泌体[J].生物化学与生物物理进展,2013,40(8):719-727.
[52] 解曼曼,张海涛,林文勇,等.外泌体作为药物载体的研究进展[J].中西医结合心脑血管病杂志,2019,17(22):3525-3528.
[53] SUN D, ZHUANG X, XIANG X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010;18(9):1606-1614.
[54] KALANI A, TYAGI N. Exosomes in neurological disease, neuroprotection, repair and therapeutics: problems and perspectives. Neural Regen Res. 2015;10(10):1565-1567.
[55] HOOD JL. Post isolation modification of exosomes for nanomedicine applications. Nanomedicine (Lond). 2016;11(13):1745-1756.
[56] KALANI A, KAMAT PK, CHATURVEDI P, et al. Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia. Life Sci. 2014;107(1-2):1-7.
[57] WANG H, SUI H, ZHENG Y, et al. Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK-3β pathway. Nanoscale. 2019;11(15):7481-7496.
[58] 周霞,张文倩,刘炬,等.从血管内皮生长因子及其受体调控角度探讨地黄梓醇促血管新生作用及分子机制研究[J].实用心脑肺血管病杂志,2020,28(2):64-68.
[59] 罗辉,吴志方,沈玮,等.梓醇对大鼠骨髓间充质干细胞体外增殖和成软骨分化能力的影响[J].中华中医药学刊,2020,38(2):149-153.
[60] LIU Y, FU N, SU J, et al. Rapid Enkephalin Delivery Using Exosomes to Promote Neurons Recovery in Ischemic Stroke by Inhibiting Neuronal p53/Caspase-3. Biomed Res Int. 2019;2019:4273290.
[61] ZHONG X, LUO C, DENG M, et al. Scutellarin-treated exosomes increase claudin 5, occludin and ZO1 expression in rat brain microvascular endothelial cells. Exp Ther Med. 2019;18(1):33-40.
[62] 刘梦琳,樊根豪,安瑞丽,等.灯盏花素注射液辅助治疗急性脑梗死的Meta分析[J].中成药,2020,42(4):921-926.
[63] YANG J, GAO F, ZHANG Y, et al. Buyang Huanwu Decoction (BYHWD) Enhances Angiogenic Effect of Mesenchymal Stem Cell by Upregulating VEGF Expression After Focal Cerebral Ischemia. J Mol Neurosci. 2015; 56(4):898-906.
[64] KIM MS, HANEY MJ, ZHAO Y, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine. 2016;12(3):655-664.
[65] YU P, CHEN W. Advances in the diagnosis of exosomal miRNAs in ischemic stroke. Neuropsychiatr Dis Treat. 2019;15:2339-2343.
[66] MA ZJ, YANG JJ, LU YB, et al. Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine. World J Stem Cells. 2020;12(8):814-840.
|